MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Journal Article

Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia

2023
Request Book From Autostore and Choose the Collection Method
Overview
Patients with congenital adrenal hyperplasia require lifelong therapy with glucocorticoids to suppress androgen excess and substitute for deficient cortisol. An important aspect of care is the prevention of metabolic sequelae. In infants, potentially lethal nocturnal hypoglycaemia has been described. In adolescence, visceral obesity, hypertension, hyperinsulinism and insulin resistance come into focus. To date, systematic studies of glucose profiles are lacking. We conducted a monocentric prospective observational study to determine the glucose profiles under different treatment regimens. We used the latest generation FreeStyle Libre 3® sensor in blinded mode as a device for CGM. Furthermore, therapeutic/ auxological data were obtained. Our cohort of 10 children/ adolescents had a mean age of 11 years. Three patients showed morning fasting hyperglycaemia. Overall, 6 out of 10 patients had too little total values in the desired range of 70-120 mg/dl. Tissue glucose values above 140-180 mg/dl were found in 5 of 10 patients. All patients had an average value for glycosylated haemoglobin of 5.8 %. All pubertal adolescents with reverse circadian regimens had significantly higher glucose levels at night. Two adolescents showed asymptomatic nocturnal hypoglycaemia. A high number of subjects showed abnormalities in glucose metabolism. Two-thirds had elevated total 24h glucose values outside the age-appropriate reference values. Thus, this aspect may need to be addressed early in life by adjusting the doses, treatment regimen or dietary measures. Consequently, reverse circadian therapy regimens should be critically indicated and closely monitored due to the potential metabolic risk.